Skip to content
Buzytel TonęLab
Starter Duo — Toner Pad + Cream
Concept packaging only. Final formula, packaging, and product details are not confirmed.

Low Barrier

Starter Duo — Toner Pad + Cream

$4170 pads + 50 ml

Planning figures — not yet confirmed

The shortest path from owning one product to having an actual routine.

Actives

TX Line2-step entry

The shortest path from one product to an actual routine.

Who it is for
For anyone who already owns a single cream and is not ready to buy six things. Also the natural second purchase once a single unit has stopped producing change.
The problem
The jump from one product to a full kit is too large, and most buyers stall permanently somewhere in that gap.
How it works
Treat, then moisturise. The pad delivers a low, repeatable dose of acid plus tranexamic acid; the cream carries the higher concentration and repairs the barrier between pad sessions.
How to use
Pads once daily, cream morning and night. Build from three pad sessions per week in the first fortnight.

What supports it

  • TX-04 pad plus TX-01 cream — the two highest-traffic SKUs in the line.
  • Enters the 40 to 60 dollar band at its lowest rung.
  • Roughly twelve percent below the pieces bought separately.
  • 4.5 stars across 446 reviews.

In short

  • The most common second purchase in the line.
  • Upgrades a single-unit buyer without demanding a six-piece commitment.
  • Fits the highest-output price band at the lowest entry cost.
  • No new habits to learn beyond one extra step.

What to expect, and when

  1. Week 1–2Three pad sessions weekly plus daily cream. Tolerance building, not treatment.
  2. Week 4–6Move to daily pads if comfortable. Texture improves first.
  3. Week 8–12Full assessment window. Add TX-03 serum if progress has plateaued.

Compatibility

Pairs with

  • KT-02 spray if you want to extend the routine to the body.
  • SPF each morning — the pad increases turnover, which increases photosensitivity.

Do not combine

  • Do not stack with: other exfoliating acids on pad days.

Others in this line